Gastroenteropancreatic Neuroendocrine Tumors – Guidelines Spotlight
In this edition of our Guideline Spotlight, we will explore the key insights and takeaways from the American Society of Clinical Oncology’s (ASCO) comprehensive guideline, Systemic Therapy for Tumor Control in Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This guideline offers evidence-based recommendations for the treatment of advanced or metastatic GEP-NETs, a rare group of tumors […]
Read More